Personally I don't mind having a balanced opinion. It hurts me to my core to see the SP action, and I am not educated well enough to fully understand all the implications of the trial, others here are far better positioned. But I do take John's point with regards to market interpretation. Whether the market wasn't happy with the results (struggle to believe that) or if bigger forces are at play, the short term SP is really not on my radar. Getting into production by 2025, developing all the other programs and playing a game of dodge ball with any larger players to avoid a TO are my main areas of concern. Brilliant results, IHL always has been and will remain a long term play for me. GLTAH
- Forums
- ASX - By Stock
- IHL
- Ann: IHL-42X positive phase 2 clinical trial results
Ann: IHL-42X positive phase 2 clinical trial results, page-255
-
- There are more pages in this discussion • 135 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)